Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.28M Buy
+100,000
New +$1.39M ﹤0.01% 2876
2026
Q1
– Sell
-58,500
Closed -$959K – 5329
2025
Q4
$959K Buy
+58,500
New +$910K ﹤0.01% 3457
2024
Q2
– Sell
-76,700
Closed -$1.74M – 5189
2024
Q1
$1.74M Buy
+76,700
New +$1.8M ﹤0.01% 2692
2023
Q4
– Sell
-80,000
Closed -$1.37M – 5320
2023
Q3
$1.37M Buy
+80,000
New +$1.33M ﹤0.01% 2124
2022
Q2
– Sell
-55,200
Closed -$1.19M – 5198
2022
Q1
$1.19M Buy
+55,200
New +$1.86M ﹤0.01% 2269

Other funds holding PATH

Barclays's PATH Position: Q3 2026 in Review

Barclays increased its UiPath (PATH) stake by 24% in Q3 2026, buying an estimated $3.37M and bringing the position to 1,257,532 shares worth $16.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Barclays first reported a position in PATH in Q1 2022 and has held it in 19 quarters since. The position peaked at $25.8M in Q4 2025. 243 funds tracked by Wall St. Rank hold PATH as of Q3 2026.

  • Barclays held 1,257,532 shares of UiPath worth $16.1M as of Q3 2026.
  • Barclays bought 242,246 UiPath shares in Q3 2026, an estimated $3.37M.
  • UiPath made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1367 holding.
  • Barclays first reported a position in UiPath in Q1 2022 and has held it in 19 quarters since.
  • Barclays's UiPath position peaked at $25.8M in Q4 2025.
  • 243 funds tracked by Wall St. Rank held UiPath as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.